CRC Funding Program



To further develop outstanding cancer research, the UZH and Medical Faculty have established the competitive CRC funding program (CHF 4.9 Mio., 2018-2021) supporting multidisciplinary, translational research projects of scientists and physician-scientists at the CCCZ.

Principal Investigators from the CCCZ are invited to be part of an innovative, interdisciplinary research team helping to rapidly transfer basic science discoveries into clinical application. To qualify for support, research projects must involve at least one scientist and one physician-scientist. It is encouraged that both partners are CRC members; at least one of the partners must be CRC member.

Competitive funding is available in the form of fellowships covering the salary or protected research time of outstanding scientists and physician-scientists engaged in collaborative projects between groups from preclinical and clinical fields. Currently, five 2-year fellowships will be funded every year.

UZH NEWS
Read more about the 2018 CRC Call and the CCCZ.

CRC FUNDING PROGRAM - 3rd Call

CRC Funding Program - 3rd Call (2020)

We invite you to be part of an interdisciplinary research team helping to make breakthrough discoveries in basic, translational and clinical cancer research and develop those into novel diagnostic procedures and therapeutic interventions for adults and children with cancer.

Timelines and Evaluation Procedures

  • 1.10.2019 – 3rd Call CRC Funding Program
  • 1.12.2019 – Submission Deadline
  • Dec 2019 – Jan 2020: Evaluation of all proposals by a panel of external scientists (each proposal will be evaluated by at least three reviewers)
  • Jan 2020 - Recommendation for funding by the Deputy Dean of the UZH Medical Faculty and communication of evaluation results to all applying PIs
  • 15.2.2020 -  Earliest funding start


For further information please see the application documents below.

Application Documents and Guidelines


Contact
Maja Zenz PhD
Managing Director CRC ZURICH
maja.zenz@uzh.ch

+41 44 635 3724

FUNDED CRC PROJECTS  - 1st Call 2018

The CRC funding program is a pivotal instrument for the strategic development of the CRC ZURICH and will strengthen the CRC research programs. Within the frame of the first call (2018), seven projects were recommended for funding by a panel of external renowned scientists. We are very pleased to announce that two of the seven projects are funded by the ISREC Foundation (please see table below).

UZH NEWS
Read more about the CRC funding program and the CCCZ.

​PRINCIPLE INVESTIGATORS ​PROJECT TITLE
Prof. Dr. Anne Müller
Institute for Molecular Cancer Research
University of Zurich
Prof. Dr. med. Thorsten Zenz
Department of Hematology and Oncology
University Hospital Zurich
Targeting the tumor microenvironment in B-cell malignancies: exploiting patient-derived xenografts for the rational pre-clinical testing of interventions that result from drug and genetic screening MORE
Prof. Dr. Martin Pruschy
Research Unit for Applied Radiobiology, Department of Radiation Oncology, University Hospital Zurich
Prof. Dr. med. Onur Boyman
Clinical lmmunology, University of Zurich and Department of lmmunology, University Hospital Zurich
Alternative combined radioimmunotherapy to overcome treatment-related resistances MORE
​Prof. Dr. Massimo Lopes
Institute of Molecular Cancer Research
University of Zurich
Prof. Dr. med. Achim Weber
Department of Pathology and Molecular Pathology, University of Zurich and University Hospital Zurich
Deciphering tumorigenesis driven by replication-associated DNA damage MORE
*Funded by the ISREC Foundation


Prof. Dr. Michael O. Hottiger
Department of Molecular Mechanisms of Disease University of Zurich
PD Dr. med. Peter Schraml
Department of Pathology and Molecular Pathology University Hospital Zurich
Validation of mono-­ADP-­ribosylated proteins as diagnostic and prognostic tool in oncology MORE
​Prof. Dr. Maries van den Broek
Institute of Experimental Immunology
University of Zurich
Prof. Dr. med. Lukas Flatz
Senior Consultant in Dermato-oncology, Department of Oncology and Department of Dermatology Kantonsspital St.Gallen
Tertiary lymphoid structures in metastatic melanoma and non-small cell lung cancer tissues as predictive markers for the outcome of checkpoint inhibitor treatment MORE
Prof. Dr. Mitchell Levesque
Department of Dermatology
University Hospital Zurich and University of Zurich
Prof. Dr. med. Matthias Guckenberger
Department for Radiation Oncology
University Hospital Zurich

​Immuno-Radiomics as a novel prognostic and predictive biomarker in malignant melanoma treated with immune checkpoint inhibition - a multi-systems approach MORE

Prof. Dr. Lukas Sommer
Institute of Anatomy
University of Zurich
Prof. Dr. med. Reinhard Dummer
Department of Dermatology
University Hospital Zurich
Investigating the functional role of cellular phenotypes in melanoma targeted therapy MORE
*Funded by the ISREC Foundation
FUNDED CRC PROJECTS  - 2nd Call 2019

Within the frame of the second call, six projects were recommended for funding by a panel of external renowned scientists.

​PRINCIPLE INVESTIGATORS
PROJECT TITLE
Prof. Dr. Konrad Basler
Institute of Molecular Life Sciences
University of Zurich
Prof. Dr. med. Dr. phil. Gerhard Rogler
Department of Gastroenterology and Hepatology University Hospital Zurich
Decrypting the crosstalk between a developing colorectal tumor and its micro-environment MORE
Prof. Dr. Raffaella Santoro
Department of Molecular Mechanisms of Disease
University of Zurich
Prof. Dr. med Dr. sc. nat. Jean-Pierre Bourquin Children’s Research Center, Leukemia Research Unit Balgrist Campus
Childrens’ Hospital Zurich
Targeting the transcriptional network architecture driven by the oncogenic TCF3-HLF Fusion MORE
Prof. Dr. Tuncay Baubec
Department of Molecular Mechanisms of Disease, Laboratory of Systems Biology of Gene Regulation
University of Zurich
Prof. Dr. med. Michael Weller
Department of Neurology, Laboratory of Molecular Neurooncology
University Hospital and University of Zurich
An integrative approach to characterize and exploit the epigenetic landscape in glioblastoma MORE
Prof. Dr. Lubor Borsig
Institute of Physiology
University of Zurich
Prof. Dr. med. Michael Scharl
Department of Gastroenterology and Hepatology University Hospital Zurich
Butyrate-producing bacteria ameliorate CRC tumorigenesis through modulation of immune responses MORE
Prof. Dr. Jacob Corn
Department of Biology
ETH Zürich
Prof. Dr. med. Markus G. Manz
Department of Medical Oncology and Hematology
University Hospital Zurich and University of Zurich
Human clonal hematopoiesis and its effect on human tumor growth in humanized mice MORE
Prof. Dr. Burkhard Becher
Institute of Experimental Immunology
University of Zurich
PD Dr. med. Alexandre Theocharides
Department of Medical Oncology and Hematology
University Hospital Zurich
The immune environment of acute myeloid leukemia MORE
CRC FELLOWS
Boudesco C_photo.jpg
FELLOW
Christophe Boudesco, PhD
CV

​PROJECT
Targeting the tumor microenvironment in B-cell malignancies: exploiting patient-derived xenografts for the rational pre-clinical testing of interventions that result from drug and genetic screening MORE

MENTORS
Prof. Dr. Anne Müller
Institute for Molecular Cancer Research, UZH
Prof. Dr. med. Thorsten Zenz
Department of Hematology and Oncology, USZ

FELLOW
Carmen Yong, PhD
​PROJECT

Alternative combined radioimmunotherapy to overcome treatment-related resistances MORE

MENTORS
Prof. Dr. Martin Pruschy
Research Unit for Applied Radiobiology, Department of Radiation Oncology, USZ
Prof. Dr. med. Onur Boyman
Department of lmmunology, USZ

FELLOW
Laure-Alix Clerbaux, PhD

​PROJECT
Deciphering tumorigenesis driven by replication-associated DNA damage MORE 
*Funded by the ISREC Foundation

MENTORS
Prof. Dr. Massimo Lopes
Institute of Molecular Cancer Research, UZH
Prof. Dr. med. Achim Weber
Department of Pathology and Molecular Pathology, USZ

Aimi_CV Picture small.jpg
​FELLOW
Fabio Aimi, PhD


​PROJECT
Validation of mono-­ADP-­ribosylated proteins as diagnostic and prognostic tool in oncology MORE

Pop_Oltin_MFZ_002.jpg
FELLOW
Oltin T. Pop, MD, PhD
CV

PROJECT
Tertiary lymphoid structures in metastatic melanoma and non-small cell lung cancer tissues as predictive markers for the outcome of checkpoint inhibitor treatment MORE

MENTORS
Prof. Dr. Maries van den Broek
Institute of Experimental Immunology, UZH
Prof. Dr. med. Lukas Flatz
Department of Oncology and Department of Dermatology, Kantonsspital St.Gallen, UZH

Basler_Photo_LB.jpg
FELLOW
Lucas Basler, MD
CV

​PROJECT
Immuno-Radiomics as a novel prognostic and predictive biomarker in malignant melanoma treated with immune checkpoint inhibition - a multi-systems approach MORE

MENTORS
Prof. Dr. Mitchell Levesque, Department of Dermatology, USZ
Prof. Dr. med. Matthias Guckenberger, Department for Radiation Oncology, USZ

FELLOW
Jelena Vasilevska, PhD
CV

​PROJECT
Investigating the functional role of cellular phenotypes in melanoma targeted therapy MORE
*Funded by the ISREC Foundation

MENTORS
Prof. Dr. Lukas Sommer, Institute of Anatomy, UZH
Prof. Dr. med. Reinhard Dummer, Department of Dermatology, USZ


FELLOW
Ana Montalban-Arques, PhD
CV

​PROJECT
Butyrate-producing bacteria ameliorate CRC tumorigenesis through modulation of immune responses MORE


FELLOW
Valdemar Priebe, PhD
CV
​PROJECT

Targeting the transcriptional network architecture driven by the oncogenic TCF3-HLF Fusion MORE


FELLOW
Hassan Fazilaty, PhD
CV

​​PROJECT
Decrypting the crosstalk between a developing colorectal tumor and its micro-environment

 

   

CRC Membership

Basic and physician.scientists of UZH, USZ, ETH and other Swiss Universities can apply to become a CRC member by submitting the completed membership application form to Maja Zenz. Applicants will usually be informed within a month. 

MEMBERSHIP CRITERIA

  • Faculty member of the Medical Faculty, the Faculty of Science or Vetsuisse Faculty OR having the right to confer a PhD at the Faculty of Science. Faculty members of ETH or other Swiss universities may be admitted, if this is supported by three CRC members; however, such external members are not eligible to receive UZH funding - for now.

    AND

  • Having an own research grant from the SNSF, OncoSuisse, European Community or NIH.
MEMBERS' MEETINGS

Up-coming meetings will be announced in the near future.

PAST MEETINGS 2019
24-26.3.2019 - 2019 Scientific Retreat of the Comprehensive Cancer Center Zurich
24.3.2019 - CRC Members Assembly

 

Current Overview of CRC Members

 
CRC Members A-F

Matthias Altmeyer
Konrad Basler
Tuncay Baubec
Martin Baumgartner
Burkhard Becher
Felix Beuschlein
Bernd Bodenmiller
Beat Bornhauser
Lubor Borsig
Jean-Pierre Bourquin
Onur Boyman
Amedeo Caflisch
Pierre-Alain Clavien
Jacob Corn
Michael Detmar
Raghvendra Dubey
Reinhard Dummer
Daniel Eberli
Daniel Fink
Lukas Flatz

CRC Members G-K

Kerstin Gari
Urs Greber
Matthias Guckenberger
Alex Hajnal
Jason Holland
Michael Hottiger
Pavel Janscak

CRC Members L-R

Kuno Lehmann
Mitch Levesque
Massimo Lopes
Markus Manz
Giancarlo Marra
Holger Moch
Andreas Moor
Christian Mosimann
Anne Müller
Christian Münz
Hanspeter Nägeli
Darius Neri
Felix Niggli
Cesar Nombela-Arrieta
Lorenza Penengo
Andreas Plückthun
Martin Pruschy
Gerhard Rogler

CRC Members S-Z

Raffaella Santoro
Alessandro Sartori
Beat Schäfer
Michael Scharl
Roger Schibli
Isabelle Schmitt-Opitz
Lukas Sommer
Rolf Stahel
Christian Stockmann
Manuel Stucki
Tullio Sulser
Maries van den Broek
Achim Weber
Sabine Werner
Walter Weder
Michael Weller
Lynn Wong

 

 


We use cookies to make our website user-friendly, to continuously improve it and to analyze the traffic of our website. By continuing to browse the site, you are agreeing to our use of cookies. Further information can be found in our privacy policy.